CARsgen is proud of its collaborative relationships with leading partners in cancer research and clinical development.

Strategic Partner

Shanghai Cancer Institute

The Shanghai Cancer Institute was established in 1958 and is affiliated with the Shanghai Health Planning Commission. In 1980, it was recognized as a WHO Collaborative Center for Cancer Prevention and Control. In 1985, it was chosen to establish the State Key Laboratory of Oncogenes and Related Genes. In 1996, the Shanghai Science and Technology Commission jointly established a pilot-scale gene therapy research base in Shanghai. In 2003, the Shanghai Cancer Institute was renamed as the Institute of Oncology of Shanghai Jiaotong University. And in 2010, the Shanghai Cancer Institute was integrated with Renji Hospital of Jiaotong University.

Collaborative Partners

Renji Hospital

Renji Hospital is a general hospital in Shanghai China, with the rank of "Grade 3, Class A". The hospital is a university hospital affiliated to Shanghai Jiao Tong University School of Medicine.

Changhai Hospital

Changhai Hospital is a university hospital affilated to the People's Liberation Army Naval Medical University, also known as the PLA Second Military Medical University (SMMU), which is a public university in Shanghai China.